Confirm diagnosis
Other causes of lighter skin patches can resemble vitiligo.
MEDICAL DERMATOLOGY • VITILIGO • PIGMENT
Diagnosis and personalised management for vitiligo, with treatment selected according to activity, location, extent and patient goals.
ABOUT THE TREATMENT
Vitiligo causes loss of pigment because melanocytes are damaged by an autoimmune process. It can remain stable, spread or affect different body sites in different ways.
Your concern, relevant history and treatment goals are reviewed before suitability is discussed.
The treatment pathway is adapted to your assessment, priorities and realistic goals rather than a fixed protocol.
Technique, intensity and treatment details are selected conservatively according to the service and your individual needs.
Aftercare and follow-up are used to assess response, support recovery and decide whether further treatment is appropriate.
TREATMENT FOCUS
Treatment planning focuses on the factors most relevant to this service, your diagnosis or concern, and safe, realistic outcomes.
Other causes of lighter skin patches can resemble vitiligo.
We consider whether lesions are stable or changing when planning treatment.
Response differs by body area, duration and remaining hair-follicle pigment.
Distribution, recent spread, skin type and treatment history help guide discussion and ongoing monitoring.
IN MORE DETAIL
Treatment may include topical medicines, light therapy or other dermatologist-directed options. No single treatment works for everyone, and response can be slower in some areas such as hands and feet.
At Lumera Derm, treatment choice follows assessment. The aim is to match the option to the concern, skin or scalp condition, medical history and realistic goals rather than treating a service name as a one-size-fits-all solution.
YOUR VISIT
Each service follows the same principle: assess first, explain options clearly, then treat only when appropriate.
Discuss the concern, goals, relevant history and any previous treatment.
Confirm suitability, risks, alternatives and whether another pathway would be more appropriate.
Agree on a conservative, personalised plan with realistic expectations.
Follow-up is used to assess response and decide whether any further treatment is worthwhile.
SAFETY & SUITABILITY
New rapidly spreading depigmentation, eye symptoms or associated autoimmune concerns should be discussed with a clinician. Treatment choice depends on individual context.
FREQUENTLY ASKED
Clear answers to common questions before you book.
BOOK A CONSULTATION
Ask questions, understand suitability and decide on the next step without unnecessary forms.